Compare
C3.ai, Inc. vs Cerence Inc. vs Definitive Healthcare Corp. vs Vtex
| Latest fiscal year | C3.ai, Inc. AI | Cerence Inc. CRNC | Definitive Healthcare Corp. DH | Vtex VTEX |
|---|---|---|---|---|
| Year ended | 2026-04-30 | 2025-09-30 | 2025-12-31 | 2025-12-31 |
| Revenue | $250.27M | $251.78M | $241.52M | $240.52M |
| Revenue growth (YoY) | -35.7% | -24.0% | -4.2% | +6.1% |
| Gross margin | 30.9% | 72.7% | 75.9% | 77.5% |
| Operating margin | -199.2% | -0.9% | -92.9% | 7.5% |
| Net margin | -187.9% | -7.4% | -57.5% | 8.3% |
| Net income | -$470.37M | -$18.71M | -$138.93M | $20.01M |
| EPS (Diluted) | -$3.35 | -$0.43 | -$1.30 | $0.11 |
| Operating cash flow | -$190.23M | $61.17M | $53.78M | $33.37M |
| Free cash flow | -$192.14M | $46.82M | $37.06M | $32.33M |
| Cash & equivalents | $66.20M | n/a | $163.63M | $15.74M |
| Total assets | $816.27M | $630.59M | $735.49M | $346.63M |
| Total liabilities | $162.52M | $479.92M | $356.50M | n/a |
| Shareholders' equity | $653.75M | $150.68M | $378.99M | $233.56M |
| Return on year-end equity | -71.9% | -12.4% | -36.7% | 8.6% |
| Shares outstanding | n/a | 43.37M | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | C3.ai, Inc. | Cerence Inc. | Definitive Healthcare Corp. | Vtex |
|---|---|---|---|---|
| Latest | $250.27M Ended 2026-04-30 | $251.78M Ended 2025-09-30 | $241.52M Ended 2025-12-31 | $240.52M Ended 2025-12-31 |
| 1 year earlier | $389.06M Ended 2025-04-30 | $331.50M Ended 2024-09-30 | $252.20M Ended 2024-12-31 | $226.66M Ended 2024-12-31 |
| 2 years earlier | $310.58M Ended 2024-04-30 | $294.48M Ended 2023-09-30 | $251.41M Ended 2023-12-31 | $200.83M Ended 2023-12-31 |
| 3 years earlier | $266.80M Ended 2023-04-30 | $327.89M Ended 2022-09-30 | $222.65M Ended 2022-12-31 | n/a |
| 4 years earlier | $252.76M Ended 2022-04-30 | $387.18M Ended 2021-09-30 | $166.15M Ended 2021-12-31 | n/a |